A New Era for Menopause: What the FDA’s Update Means for Your Hormones

When I first started treating women with menopause symptoms 15 years ago, many practitioners stayed far away from prescribing hormone therapy because the “black box” warning slapped on estrogen products felt like a red flag. Breast cancer, heart disease, stroke, dementia—these all sound so scary. Unfortunately, that warning influenced a generation of women to reject hormone therapy, even when they were struggling with severe menopausal symptoms. But the message has just changed. On November 10, 2025, the U.S. Food and Drug Administration (FDA) formally initiated removal of that warning from most menopausal hormone therapy (MHT) products.

Marty Makary, United States Commissioner of Food and Drugs, explained in a public statement that the update reflects a comprehensive, decades-long reexamination of the scientific literature: “For too long, issues of women’s health have been underrecognized. Women and their physicians should make decisions based on data, not fear.”

That’s powerful. Because what it means, especially for women in our community navigating perimenopause or menopause, is that hormone therapy is no longer automatically slotted into the “dangerous” category. This is a huge win!

What Changed and Why It Matters

The original warning dates back to 2003, when initial results from the Women’s Health Initiative (WHI) suggested increased risks of breast cancer, cardiovascular disease, and dementia for women using hormone therapy. Those findings led to a dramatic drop in prescriptions and left many women suffering in silence. 

But the WHI participants were, on average, in their 60s, already well past the onset of menopause. More recent evidence shows that age and timing matter: Starting hormone therapy within 10 years of menopause onset, or before about age 60, appears to carry a much more favorable balance of risks and benefits. No longer do you need to be suffering in order to be “eligible” for treatment. We are now treating women to prevent symptoms and to prevent long term health problems.   

Thankfully, the newer hormone therapies and delivery methods, such as patches, gels, low-dose vaginal estrogen creams or rings, are different from those used in the original WHI trial. As American College of Obstetricians and Gynecologists (ACOG) noted, the blanket warning that was applied for decades treated all estrogen products as having identical risk. That’s now recognized as medically inaccurate and potentially harmful.

What Leading Experts Are Saying

Jan L. Shifren, MD, director of the Midlife Women’s Health Center at Massachusetts General Hospital, points out that the old warnings came from a specific, older patient population, and for many women the risk-benefit profile now looks very different. “For women who start hormone therapy under age 60 or within 10 years of menopause,” she explains, “the benefits often outweigh the risks.” 

Similarly, other clinicians argue that hormone therapy, when individualized, remains the most effective treatment for menopausal symptoms, such as hot flashes, night sweats, vaginal dryness, disrupted sleep, and even bone density loss. The removal of the black box warning reflects evolving science, and validates many practitioners, like myself, who have been prescribing hormones and helping women for over a decade.  

What This Means for You — And Why You Should Consider a Consultation

If you’ve ever dismissed hormone therapy out of fear or felt concerned reading that scary label, now is the time to reconsider. This isn’t about glorifying hormones as a cure-all. It’s about giving women real, evidence-based options.

When I meet with busy women juggling career, family, and community, I find that many are pleasantly surprised to learn that there is an option for safe, effective relief from perimenopausal and menopausal symptoms. Hormone therapy isn’t for everyone, and it must be tailored carefully based on your health history, risk factors, and personal priorities. But for many, it can markedly improve quality of life during midlife and even have long-term health benefits for heart, bone, and brain.

If you’re in your 40s or 50s, experiencing persistent or even intermittent hot flashes, poor sleep, mood swings, vaginal dryness, or other troublesome changes, and you want to feel like yourself again, now may be a good moment to have an updated, personalized hormone consultation.

The science has changed, the warnings have changed, and for many women, menopause doesn’t have to feel like a disease. It can be a transition managed with clarity, dignity, and empowerment.

Your Guide to the New FDA Hormone Therapy Update

Why This Matters Now

The FDA has officially removed the long-standing black box warning from most estrogen products — acknowledging that the old label overstated risks for many women entering menopause.

Who Stands to Benefit Most

Women under 60 or within 10 years of menopause often experience:

• Fewer hot flashes and night sweats
  
• Improved sleep
  
• Better mood stability
  
• Healthier bones
  
• Enhanced vaginal and sexual comfort
  

What Has NOT Changed

Hormone therapy still requires customization. Your unique health history, risk factors, and goals determine the safest and most effective plan.

What a Modern Hormone Consultation Includes

• Full medical and symptom review
  
• Cardiovascular and cancer risk stratification
  
• Discussion of lifestyle, stress, sleep, and metabolism
  
• Options, such as transdermal estrogen, bioidentical progesterone, testosterone, and integrative supports
  
• A personalized roadmap based on the latest science